A randomized, double-blind, parallel, placebo-controlled study to evaluate the efficacy and safety of tadalafil (2.5mg and 5mg) administered once daily to men with erectile dysfunction

Trial Profile

A randomized, double-blind, parallel, placebo-controlled study to evaluate the efficacy and safety of tadalafil (2.5mg and 5mg) administered once daily to men with erectile dysfunction

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Lilly ICOS
  • Most Recent Events

    • 07 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top